ASE; SDS-PAGE; MALDI-TOF MS and MALDI-TOF MS/MS combined provide an efficient method for identification of ricin.

1. Introduction {#sec1-toxins-11-00201}
===============

Ricin is a highly toxic protein which can be extracted from the castor bean seeds (*Ricinus communis* L.). This plant is present in all Brazilian regions and explored commercially for its oil, which is mainly used for the production of lubricants, fuel and drugs. Currently, Brazil is the fourth world producer of castor bean oil, just behind India, China and Mozambique \[[@B1-toxins-11-00201],[@B2-toxins-11-00201]\]. The production of 1.0 ton of oil generates around 1.2 ton of residue, known as castor cake \[[@B3-toxins-11-00201]\]. The literature reports different values for the ricin content in the castor cake, varying between 0.04% and 0.08% (w/w), depending on the cultivars, the extraction method, and the analysis \[[@B4-toxins-11-00201],[@B5-toxins-11-00201],[@B6-toxins-11-00201]\]. Castor cake is an excellent source of nutrients for cattle; however, its content of ricin can intoxicate the animals. In addition, the disposal of this residue in the environment represents a risk for the population. The detoxification methods proposed so far for the castor cake are expensive, time and energy demanding, and do not guarantee the total destruction of ricin without formation of other toxic products. The analyses are usually based on oral toxicity and other experiments with animals that can be influenced by several factors like species, age, and feeding time. Spectrometric techniques for identification and quantification of the products formed have rarely been used for these studies \[[@B7-toxins-11-00201],[@B8-toxins-11-00201]\].

Ricin has toxicity similar to the neurotoxic agent sarin and can be easily extracted from the castor bean (*R. communis* L.) seeds as a fine white powder, water soluble, and stable at a large range of pH. For this reason, it is considered a chemical/biological warfare agent scheduled by both the chemical weapons convention (CWC) \[[@B9-toxins-11-00201]\], and the biological weapons convention (BWC) \[[@B10-toxins-11-00201]\]. It can be disseminated in the air as fine particles with a diameter smaller than 5 microns or used to contaminate water supplies or agricultural products. This turns ricin into a perfect agent for terrorist attacks and a matter of big concern for national authorities worldwide \[[@B11-toxins-11-00201],[@B12-toxins-11-00201],[@B13-toxins-11-00201],[@B14-toxins-11-00201]\].

The structure of the ricin molecule is made up of two different chains, named RTA and RTB, connected by a disulfide bond. RTA is an N-glycosidase containing 267 amino acids arranged in eight α-helices and eight β-strands, distributed in three structural domains, forming a "U" shaped cleft containing the protein active site. RTB is a lecithin composed of 262 amino acids, containing neither α-helices nor β-strands \[[@B12-toxins-11-00201],[@B15-toxins-11-00201],[@B16-toxins-11-00201]\]. Due to its mechanism of action in the organism, and for being a heterodimer, ricin is classified as a ribosome inactivating protein (RIP) of type II \[[@B16-toxins-11-00201],[@B17-toxins-11-00201],[@B18-toxins-11-00201]\]. RTB is responsible for the binding of ricin to the terminal galactose residues of the glycolipids and glycoproteins present on the surface of eukaryotic cells \[[@B12-toxins-11-00201]\]. This enables the formation of a vesicle surrounding the toxin, which guides it into the inner part of the cell through endocytosis. Once inside the endosome, many ricin molecules are transported back to the outside of the cell or for the lysosomes, where they are degraded. However, some of them manage to reach the Golgi complex, following in retrograde movement, until the endoplasmic reticulum, where their disulfide bonds are cleaved, splitting RTA and RTB. After, RTA is transferred to the cytosol where it reacts specifically with the ribosomal RNA (rRNA) 28S of the ribosomal subunit 60S, provoking the hydrolysis of the N-glycoside bond of the adenine residue at position 4324 (A4324) \[[@B13-toxins-11-00201],[@B19-toxins-11-00201],[@B20-toxins-11-00201],[@B21-toxins-11-00201]\].

The current decontamination process of people exposed to ricin consists only on the removal of clothes, followed by washing the skin with running water \[[@B11-toxins-11-00201]\]. In cases of ingestion, the patient should be immediately submitted to gastrointestinal lavage \[[@B22-toxins-11-00201]\]. There is no specific antidote for poisoning with ricin yet, neither a commercial vaccine \[[@B22-toxins-11-00201],[@B23-toxins-11-00201]\]. Many works have been performed in the last decade towards the development of a vaccine, including tests with humans. Results have been promising, however, no final product has been approved yet \[[@B22-toxins-11-00201],[@B23-toxins-11-00201],[@B24-toxins-11-00201],[@B25-toxins-11-00201],[@B26-toxins-11-00201]\].

The most common methods used for detection of ricin are based on enzyme-linked immunosorbent assay, like the ELISA method, or in bioassays where the inactivation of an RNA substrate is measured. Other techniques also used are sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), real-time quantitative-polymerase chain reaction (RTQ-PCR), and toxicological analyses in cell culture and in guinea pigs \[[@B7-toxins-11-00201],[@B27-toxins-11-00201],[@B28-toxins-11-00201],[@B29-toxins-11-00201],[@B30-toxins-11-00201],[@B31-toxins-11-00201],[@B32-toxins-11-00201],[@B33-toxins-11-00201]\]. In this work, we report for the first time the accelerated solvent extraction (ASE) as an efficient method for ricin extraction from the seeds of castor bean (*R. communis* L.) followed by the combined use of SDS-PAGE, matrix-assisted laser desorption/ionization/time-of-flight mass spectrometry (MALDI-TOF MS) and MALDI-TOF MS/MS for a fast and unambiguous identification of ricin for forensic purposes. Additionally, this method was further successfully used to detect the presence of ricin in gamma-irradiated samples.

2. Results and Discussion {#sec2-toxins-11-00201}
=========================

2.1. Detection of the Intact Ricin Molecule by MALDI-TOF MS {#sec2dot1-toxins-11-00201}
-----------------------------------------------------------

Direct analysis of the samples through MALDI-TOF MS, led to a rapid identification of the characteristic peak of the intact molecule of ricin at *m*/*z* close to 64 kD, as shown in [Figure 1](#toxins-11-00201-f001){ref-type="fig"}. The exact position of this peak can change according to the simultaneous existence of different isoforms. The non-irradiated sample (0 kGy) showed a peak relatively intense in this region of the spectra ([Figure 1](#toxins-11-00201-f001){ref-type="fig"}), while the irradiated samples showed a reduction in intensity of this peak from 5000 a.u (non-irradiated sample) to around 1500 a.u (for sample irradiated at 10 kGy), and close to 0,000 a.u (for samples irradiated at 20 and 30 kGy). [Table 1](#toxins-11-00201-t001){ref-type="table"} reports the ratio signal/noise (S/N) for each sample, considering the triplicates analyzed. As can be seen, the irradiation dosage of 10, 20 and 30 kGy provoked average reductions of the signal to noise (S/N) of 65.9%, 91.8% and 97.5%, respectively, compared to the non-irradiated sample.

Direct analysis through MALDI-TOF MS showed useful for verification of the integrity of the ricin molecules present in the samples. The presence of a peak in the range between *m*/*z* 62,000 and 68,000 should be considered as an initial detection, indicating, in a semi-quantitative way, the possible presence of non-degraded ricin. This method has the advantage of being relatively rapid.

2.2. Unequivocal Identification of Ricin {#sec2dot2-toxins-11-00201}
----------------------------------------

According to the procedures adopted by the Organization for Prohibition of Chemical Weapons (OPCW) \[[@B9-toxins-11-00201]\], the unequivocal identification of a chemical substance related to the CWC should be made through two different analytical methods, and one of them must be spectrometric. In order to meet this criterion, the identification of the ricin presence in the samples was performed through MALDI-TOF MS, using of peptide mass fingerprint (PMF) method after extraction of the protein separated through SDS-PAGE. Confirmation of the results was done with MALDI-TOF MS/MS.

### 2.2.1. SDS-PAGE in Reducing Conditions {#sec2dot2dot1-toxins-11-00201}

Samples irradiated at 0, 10, 20 and 30 kGy were submitted to SDS-PAGE in reducing conditions. This technique allowed separation of the analytes of interest from other proteins and impurities. [Figure 2](#toxins-11-00201-f002){ref-type="fig"} shows the picture of the polyacrylamide gel from the SDS-PAGE obtained after revelation with Coomassie blue. The hydrogenation promoted by the reducing agent DTT caused the breaking of the disulfide bond between RTA and RTB. The main bands of interest were identified with numbers 1 and 2 in [Figure 2](#toxins-11-00201-f002){ref-type="fig"} according to the crescent order of its respective molecular masses. Band 2, of higher molecular weight, presented approximately double of the length of band 1 in the vertical direction. This observation suggests the possibility of a superposition of the signals of two polypeptide chains, with similar molecular weights, at band 2.

One single band from SDS-PAGE may contain more than one isoform which are differentiated from each other by the degree of glycosylation because differences in the contents of sugar generate small differences in mass \[[@B34-toxins-11-00201]\]. Fultonet et al. \[[@B35-toxins-11-00201]\] and Kim et al. \[[@B33-toxins-11-00201]\], observed that RTA isolated and purified exhibit two bands in the gel revealed with Coomassie blue, while RTB does not present any heterogeneity. Therefore, the whole molecule of ricin splits into two protein bands. The upper band is a mixture of RTB and the first isoform of RTA, while the lower band corresponds exclusively to the second isoform of RTA \[[@B33-toxins-11-00201]\]. All samples presented two bands in the SDS-PAGE gel. The sample irradiated at 30 kGy presented less intense color compared to the others. Considering that the intensity is related to the amount of protein bound to the colorant used, we can deduce that this sample contains the lower concentration of ricin.

In order to make a clear identification, the two bands were collected and analyzed by MALDI-TOF MS. Results (shown in the next topic) allowed the identification of band 1 as one of the isoforms of RTA and band 2 as a mixture between RTB and the second isoform of RTA.

### 2.2.2. Ricin Identification through MALDI-TOF MS {#sec2dot2dot2-toxins-11-00201}

The two bands in the region of interest in the SDS-PAGE gel were cut, discolored, and digested with trypsin. The peptides obtained this way were extracted from the gel and analyzed through MALDI-TOF MS. [Figure 3](#toxins-11-00201-f003){ref-type="fig"} shows the result obtained for band 1 of the non-irradiated and the sample irradiated at 30 kGy for comparison purposes.

The mass standard spectrum, also known as the fingerprint of peptides, was used for the identification of the protein. At first, the list of the peak masses was exported to the program Biotools (Bruker^®^). After, through the search mechanism MASCOT PMF, the experimental results were compared to the information available in the data banks: SwissProtb \[[@B36-toxins-11-00201]\] and National Center of Biotechnology Information (NCBI) \[[@B37-toxins-11-00201]\]. The mass standard obtained from the analysis of band 1 showed to be similar to the chain RTA, with the probability of being a random event \<0.05.

The radiolysis process may occur directly over the target molecule as a primary effect, or indirectly, through the formation and reaction of free radicals with other molecules present \[[@B38-toxins-11-00201]\]. The gamma irradiation may denature proteins and reduce the amino acids content. Some residues, like the ones containing sulfur, can be more susceptible to radiolysis \[[@B39-toxins-11-00201],[@B40-toxins-11-00201]\]. These phenomena may alter the intensity of peptides peaks as shown in [Figure 3](#toxins-11-00201-f003){ref-type="fig"}.

In [Figure 3](#toxins-11-00201-f003){ref-type="fig"} the peaks were labeled in order of maintaining the correspondence with the peptides nomenclature shown in [Table 2](#toxins-11-00201-t002){ref-type="table"}, which presents the expected masses for the complete proteolysis of ricin by trypsin. As not all theoretical scissions occurred, some peaks in [Figure 3](#toxins-11-00201-f003){ref-type="fig"} were labeled as a sum of peptides, indicating that they remained connected. [Table 2](#toxins-11-00201-t002){ref-type="table"} lists the *m*/*z* values measured with the theoretical values of the corresponding peptides, and the respective amino acid sequences and the positions occupied in RTA.

Most of the peptides were identified without modifications, by the mass of their quasi-molecular ion \[M + H\]^+^, like, for example, A6, A9, A10, A11, A12, A14, A19 and A20.

The presence of some peaks suggests that the proteolysis was incomplete, producing one single peptide while two or three were expected. This happened for signals at *m*/*z* A1 + A2, A7 + A8, A10 + A11, A13 + A14, A16 + A17 and A16 + A17 + A18.

As the peptide A7 + A8 has an estimated mass of 4083.214 Da, its quasi-molecular ion \[A7 + A8 + H\]^+^ present *m*/*z* out of the range analyzed (700--3500) and, therefore, cannot be detected. However, it is expected that its doubled protonated ion at *m*/*z* = 2042.615 \[A7 + A8 + 2H\]^2+^ be detected. This is compatible with the signal observed at *m*/*z* = 2042.4 (see [Table 2](#toxins-11-00201-t002){ref-type="table"}).

The identification of peptide A13 was not trivial due to the presence of cysteine and methionine residues at positions 171 and 174, respectively. Cysteine residues can react with the acrylamide of the gel, adding 71.04 Da to the mass of the peptide. The signal observed at *m*/*z* = 1653.9 is compatible with this modification. The methionine residue may oxidize to methionine sulfoxide, originating one single peak related to A13. It was possible to identify the presence of this peak together with A14, as a low-intensity peak at 2806.6, corresponding to A13 + A14.

Peptide A14 was also associated with two other peaks at *m*/*z* 1172.2 and 1188.2 (less intense). The difference of 16 units between them can be explained due to the oxidation of the methionine residue at position 188. The same phenomenon explains the peak of peptide A23 at *m*/*z* 2228.5.

Peptides A3, A4, A15, A16, A17, A18, A21 and A22 were not detected because their masses are \<700 Da, and, therefore, out of the range analyzed (700--3500).

The most intense signals of the spectra ([Figure 3](#toxins-11-00201-f003){ref-type="fig"}) were identified as A10 and A9, in descending order. This result is important because these two peptides allow differentiating ricin from the lectin RCA120 also present in castor bean samples. The similarity between the amino acids of RTA and RCA120 is superior to 93%. By comparing the RTBs of both proteins, this value drops to the still high value of 84% \[[@B41-toxins-11-00201]\]. So, in order to eliminate doubts in the identification, it is of fundamental importance to find intense signals of some peptides that allow differentiating ricin from RCA120, like A5, A7, A9, A10, A11, A13, A22, B14, B15, B18, B19 and B20 \[[@B42-toxins-11-00201]\].

[Table 3](#toxins-11-00201-t003){ref-type="table"} shows a comparison of the peptide sequences of RTA and RCA120 between positions 86 and 124. The difference between them is at amino acids 114 and 115, underlined in [Table 3](#toxins-11-00201-t003){ref-type="table"}. While ricin holds an arginine (R) and a tyrosine (Y) at these positions, RCA120 holds a serine (S) and a phenylalanine (F). As trypsin works on the R, the cleavage happens only between amino acids 114 and 115 of ricin. Therefore, only ricin has the peptides A9 and A10, with masses 3307 and 1310 Da. The equivalent sequence of RCA120 has one single peptide with a mass of 4513 Da.

Due to the relevance of peptides A9 and A10, and the intensity of its peaks in the mass spectra of [Figure 4](#toxins-11-00201-f004){ref-type="fig"}, the ions at *m*/*z* 3307 and 1310, were chosen for confirmation of the sequence of amino acids by MALDI-TOF MS/MS as discussed in the next topic.

MALDI-TOF MS analysis of band 1 of the SDS-PAGE gel identified the presence of RTA in the non-irradiated sample. As band 1 also shows up visible in the SDS-PAGE gels of the irradiated samples, it is reasonable to suppose that RTA is also present in these samples. In fact, this was confirmed by the mass spectra shown in [Figure 3](#toxins-11-00201-f003){ref-type="fig"} where it is possible to identify the peaks of the selected ions A9 and A10 corresponding to RTA, contrasting with a single peptide for RCA120 (see [Table 3](#toxins-11-00201-t003){ref-type="table"}).

The main peaks found in band 1 and identified as peptides of RTA, were also observed in the spectra obtained for band 2 of the SDS-PAGE gel for the non-irradiated sample, shown in [Figure 4](#toxins-11-00201-f004){ref-type="fig"}. The main difference was the presence of peptides that compose RTB that were not observed before. [Figure 4](#toxins-11-00201-f004){ref-type="fig"} and [Table 4](#toxins-11-00201-t004){ref-type="table"} present the results of the MALDI-TOF MS analysis of band 2 for the non-irradiated sample. The base ion, located at *m*/*z* 2230.9, corresponds to the peptide B13 (AEQQWALYADGSIRPQQNR).

Besides B13, we also identified B1 and B6 among the peptides expected for RTB. These two, however, presented signals with low intensity when compared to the base ion and, therefore, are magnified in [Figure 4](#toxins-11-00201-f004){ref-type="fig"}. Other three peaks correspond to the clusters B6 + B7, B15 + B16 + B17 and B17 + B18 + B19. Peaks at *m*/*z* 1533.8 and 1889.1 do not belong to ricin but correspond to the peptides B6 \* and B18 \* of RCA120, being indicatives of a third component in the upper band of the SDS-PAGE gel ([Figure 4](#toxins-11-00201-f004){ref-type="fig"} and [Table 4](#toxins-11-00201-t004){ref-type="table"}).

The identification of the peptides present in band 2 was more difficult than for band 1. First due to the presence of different chains interfering in the spectra from each other, and increasing the complexity of the matrix. Besides, several peptides from RTB possess mass values below (B2, B4, B7, B8, B9, B15 e B17) or over (B12) the range of calibration for the method used, and, therefore, could not be identified separately. Finally, even after the addition of a reducing agent (DTT) during sample preparation, some S−S bonds do not break and others may rebind naturally. Therefore, instead of producing one single peptide, many different combinations of fragments with different masses could have happened, making it difficult the identification. A usual alternative to inhibiting the formation of new disulfide bonds after sample reduction is the addition of an alkylating agent, like iodoacetamide or iodoacetic acid, which covalently binds to the thiol group of cysteine. In this case, one should consider the increase in mass due to the addition of this new group.

Despite its major complexity related to band 1, results make it clear that band 2 is composed by the superposition of signals from RTB and one of the isoforms of RTA, corroborating with the literature \[[@B33-toxins-11-00201]\]. Additionally, we also found evidence of the presence of peptides from RCA120. The presence of this contaminant is justified because this is a natural protein of castor bean plants with chains similar to ricin.

Results of the MALDI-TOF technique analysis of the irradiated samples of band 2 ([Figure 5](#toxins-11-00201-f005){ref-type="fig"}), were very similar to the non-irradiated sample discussed before. The same peptides were identified, and the main difference observed was the intensity reduction of the signals in the spectra compared to the non-irradiated sample. These results show that the use of the technique of MALDI-TOF after separation through SDS-PAGE allowed identification of the presence of ricin in all samples studied, including the ones irradiated at 30 kGy.

### 2.2.3. Analysis by MALDI-TOF MS/MS {#sec2dot2dot3-toxins-11-00201}

In order to confirm the identification of ricin by a second spectrometric technique, two peptides from RTA and one from RTB were verified by MALDI-TOF MS/MS. The first and second precursor ions selected were the ones with *m*/*z* 1310 Da and 3.307 Da, due to the high intensity of its peaks in the mass spectra, and the relevance of peptides A10 and A9 for the differentiation between ricin and RCA120. The third ion was the one corresponding to B13, with *m*/*z* 2231, for being the most intense related to RTB.

The MALDI-TOF MS/MS spectra corresponding to ion at *m*/*z* 1310 is shown in [Figure 5](#toxins-11-00201-f005){ref-type="fig"}. The data obtained from this spectrum were analyzed through the software Bruker Biotools^®^ (Version 2.2, Bruker Daltonik GmbH, Bremen, Germany), together with the search mechanism MASCOT, and compared to the data banks SwissProt \[[@B36-toxins-11-00201]\] and NCBI \[[@B37-toxins-11-00201]\]. Results were compatible with the amino acids sequence YTFAFGGNYDR, confirming the identification of peptide A10 from ricin.

[Table 5](#toxins-11-00201-t005){ref-type="table"} lists the fragments of peptide A10 identified by MALDI-TOF MS/MS. The following ions of series --y and --b of peptide A10, presented correspondence with the products generated from precursor *m*/*z* 1310: y1, y2, y3, y4, y5, y6, y7, y8 and y9; b2, b3 and b4. We also found some ions of the series a (a1, a2 and a7) and immonium, which contributed to reinforcing the interpretation of the results.

[Figure 6](#toxins-11-00201-f006){ref-type="fig"} presents the MALDI-TOF MS/MS spectra corresponding to the fragments of ion *m*/*z* 3307, and the corresponding analysis through the software Bruker Biotools^®^ together with the search mechanism MASCOT, and compared to the data banks SwissProt \[[@B36-toxins-11-00201]\] and NCBI \[[@B37-toxins-11-00201]\]. Like before, it is possible to verify that the results are compatible with the amino acid sequence AGNSAYFFHPDNQEDAEAITHLFTDVQNR, confirming the identification of the peptide A9 of ricin. As shown in [Table 6](#toxins-11-00201-t006){ref-type="table"}, the following series y and b were found: y1, y3, y4, y5, y6, y7, y8, y9, y11, y12, y13, y14, y15, y16, y17, y18, y20, y21, y22, y25 and y26, together with b3, b4, b7, b9, b12, b15, b23 and b25.

Finally, in order to definitely identify ricin in the samples, the last ion selected for the analysis by MALDI-TOF MS/MS was the *m*/*z* 2231. We tried to verify if the products formed would be compatible with the fragments of peptide B13. Results are shown in [Figure 7](#toxins-11-00201-f007){ref-type="fig"} and [Table 7](#toxins-11-00201-t007){ref-type="table"}.

The presence of ions y1, y5, y9 and y14, together with B3, B4, B6, B14 and B18, allowed confirming the similarity between the peak observed in the spectra of *m*/*z* 2331 and the sequence of amino acids of peptide B13 (AEQQWALYADGSIRPQQNR).

### 2.2.4. Determination of the Toxic Activity by MALDI-TOF MS {#sec2dot2dot4-toxins-11-00201}

The active site responsible for the toxicity of ricin is located in RTA between residues Tyr80 and Trp211. The residues playing the most important role in the mechanism of adenine removal from rRNA 28S are Tyr80, Tyr123, Glu177 and Arg180 \[[@B20-toxins-11-00201],[@B43-toxins-11-00201]\]. This information together with the PMF spectrum obtained by MALDI-TOF MS ([Figure 3](#toxins-11-00201-f003){ref-type="fig"}) allows correlating the ricin activity to peptides A8 to A13. Among them A8, A10 and A13 are the ones containing the most relevant residues \[[@B20-toxins-11-00201],[@B43-toxins-11-00201]\].

All peptides in the region of the active site of ricin were identified by MALDI-TOF MS for both the non-irradiated and the irradiated samples ([Figure 3](#toxins-11-00201-f003){ref-type="fig"}). The presence of these peptides suggests the possibility of toxic activity even in the samples irradiated at 30 kGy.

In order to confirm whether the samples presented toxic activity, a non-irradiated sample and another irradiated at 30 kGy, were incubated with a buffer solution containing DNA substrate with a nucleotide sequence similar to rRNA 28S. A buffer solution containing only the DNA substrate was used as a control. Aliquots were collected at three different times of incubation (0, 4 and 24 h) and analyzed by MALDI-TOF MS. Results are shown in [Figure 8](#toxins-11-00201-f008){ref-type="fig"}. At the beginning of the reaction (letters "a", "b" and "c" in [Figure 8](#toxins-11-00201-f008){ref-type="fig"}), all samples presented a unique set of intense peaks with *m*/*z* values starting at 3697, followed by 3719. These spectra are compatible with the mass of the intact oligonucleotide (GCGCGAGAGCGC) ([Figure 8](#toxins-11-00201-f008){ref-type="fig"}). The first signal corresponds to the quasi-molecular ion \[M + H\]^+^ and the others to adducts of salts usually present, like sodium salts \[M + Na\]^+^.

After 4 h of reaction, no alteration was observed in the control sample. However, in the samples incubated with ricin (0 and 30 kGy), it was observed a peak at *m*/*z* 3564 with very low intensity compared to the base peak \[M + H\]^+^ ([Figure 8](#toxins-11-00201-f008){ref-type="fig"}d,e,f). This same peak became much more intense in the aliquots collected after 24 h of incubation with ricin, reaching around 70% of the intensity of the base peak \[M + H\]^+^ ([Figure 8](#toxins-11-00201-f008){ref-type="fig"}h,i). The control sample presented only the set \[M + H\]^+^ and its adducts ([Figure 8](#toxins-11-00201-f008){ref-type="fig"}g). The difference of *m*/*z* between the quasi-molecular ion \[M + H\]^+^ and the peak at 3564 is of 133 units. This is compatible with the replacement of one adenine base of the nucleotide sequence by a hydrogen atom. The label \[M − A + H\]^+^ was used to identify this peak in [Figure 8](#toxins-11-00201-f008){ref-type="fig"}.

It was possible to see by MALDI-TOF spectrometry that both samples, the non-irradiated and irradiated at 30 kGy, attacked the DNA substrate, provoking the removal of the adenine nucleotide from the sequence GCGCGAGAGCGC. This result is compatible with the MALDI-TOF MS spectra of the samples where we had already identified the presence of peptides related to the active site of ricin ([Figure 3](#toxins-11-00201-f003){ref-type="fig"} and [Figure 4](#toxins-11-00201-f004){ref-type="fig"}) and shows that irradiation at 30 kGy is not enough to eliminate totally the toxic activity of ricin.

3. Conclusions {#sec3-toxins-11-00201}
==============

Our results showed that the ASE method was efficient and rapid for the extraction of ricin samples from castor bean seeds. For the best of our knowledge, it is the first time that this method is employed to ricin extraction. This method can be improved for future works, including subsequent steps of protein purification, and comparison with other forms of sample preparation reported in the literature \[[@B4-toxins-11-00201],[@B14-toxins-11-00201],[@B32-toxins-11-00201],[@B35-toxins-11-00201]\]. In addition, the use of ASE combined with SDS-PAGE, MALDI-TOF MS and MALDI-TOF MS/MS, has provided a fast and unambiguous identification method for ricin that can be used in real cases of forensic investigation of suspected samples.

The irradiation of samples provoked a strong and gradual reduction in the intensity of the molecular mass signal of ricin measured by MALDI-TOF MS. The signal related to the molecules that remained intact after irradiation at 30 kGy, was so small that it was not possible to distinguish it from the noise. The loss of molecular mass, however, did not imply in the complete destruction of the protein or elimination of the toxicity. Despite the initial results, ricin showed quite resistant to gamma-ray irradiation. This is illustrated by the fact that even after exposure to a dosage of 30 kGy the sample still presented toxic activity, being able to remove the adenine residue from the nucleotide sequence of the DNA substrate. These results can be attributed to two main factors: The first is related to the very low toxicity of ricin already reported by Olsnes \[[@B15-toxins-11-00201]\] who relates that a single unit of RTA is capable of inactivating thousands of ribosomes per minute. This makes any residual remnants of ricin potentially active. The second reason is that probably the mass loss provoked by the irradiation did not alter considerably the active site of the toxin, located in a specific region of RTA. In fact, the principal trypsin peptides of the ricin chains, including the ones related to the toxic activity, were identified in all samples, including the sample irradiated at 30 kGy.

The SDS-PAGE separation technique used followed by trypsin digestion and analyzed by MALDI-TOF MS, showed an important tool of identification, in this case, making it possible to differentiate ricin from other proteins with similar structures, like the RCA120, for example. Besides, the confirmation by a second method, where the amino acids sequence of the peptides was verified by MALDI-TOF MS/MS, provided higher credibility to the identification.

4. Materials and Methods {#sec4-toxins-11-00201}
========================

The materials and methods used for the development of this work are described below. It is important to mention that the manipulation of ricin, even in small amounts, means a huge risk and can cause death by accidental ingestion or inhalation. Besides, the production, storage and using of this toxin are severely restricted by the CWC \[[@B9-toxins-11-00201]\].

4.1. Protecting Equipment {#sec4dot1-toxins-11-00201}
-------------------------

The samples were produced in a glove box safety cabin equipped with a negative pressure system with HEPA and activated carbon filters, from the chemical biological radiological and nuclear (CBRN) defense Institute of the Brazilian army. Some procedures were also performed in the biology Institute of the Brazilian army in a safety cabin class II. Protective clothes, masks and gloves were needed for most of the experiments.

4.2. Sample Preparation {#sec4dot2-toxins-11-00201}
-----------------------

The scheme shown in [Figure 9](#toxins-11-00201-f009){ref-type="fig"} summarizes all the steps used for the preparation and analysis of the ricin samples used in this work.

4.3. Castor Bean Seeds {#sec4dot3-toxins-11-00201}
----------------------

The castor bean seed used belonged to the species *R. communis* L., cultivar IAC Guarani, harvest 2012/2012, category S2, lot 05/2012, with 96.80% of purity. They were received from the Company "BR Seeds Production and Commerce of Seeds Ltda" based in the city of Araçatuba in the São Paulo State, Brazil.

4.4. Production of the Ricin Samples {#sec4dot4-toxins-11-00201}
------------------------------------

Samples containing ricin were produced from the seeds of castor bean (*R. communis* L.) adapting the extraction method with acetone described in the literature \[[@B34-toxins-11-00201],[@B35-toxins-11-00201],[@B44-toxins-11-00201]\], for ASE. This was performed in a Dionex extractor (Thermo Fischer Scientific, Waltham, MA, USA), model ASE100, with a 100 mL cylindrical extraction cell made of stainless steel. Firstly, the seeds were peeled with the help of tweezers and a spatula, until exposing their whitish inner part. After, they were milled in an 80 mL Ika^®^ stainless steel knives mill, model A11 from Ika manufacturer. The oiled mass (4 g) was transferred to the extraction cell that was inserted in the oven of the extractor ASE100. The temperature was programmed to stay constant at 40 °C. Extraction was performed with a mixture 8:2 of the solvents n-hexane 99% UV/HPLC-Spectroscopic from Vetec (Rio de Janeiro, Brazil), and acetone 99.8% HPLC from J. T. Baker. This mixture was pumped into the cell, filling the whole volume, and raising the pressure to 1650 psi. After 5 min under this pressure, the extract obtained was filtered and collected into a flask. After removal of the extract, the cell was purged with nitrogen for 1 min and the extraction procedure repeated. After four rounds of extraction and evaporation of the solvent, around 1.2 g of a white powder containing ricin was separated from the extract for each extraction step.

All white powder produced was homogenized and separated in fractions of 1 g. Each fraction was packed into a 15 mL conic tube for centrifugation. After centrifugation, each tube was placed in a transparent plastic bag with a double closing system, identified externally and sent for irradiation. The samples were prepared in triplicate and named according to the irradiation dosages to be received (0 kGy, 10 kGy, 20 kGy and 30 kGy).

4.5. Samples Irradiation {#sec4dot5-toxins-11-00201}
------------------------

The samples were irradiated with gamma rays in the installations of the CBRN Defense Institute of the Brazilian army in a research irradiator of the armored cavity type with a source of Cs^137^, projected and constructed in 1969 in the Brookhaven National Laboratories, in the USA. The source of gamma rays consisted of 28 cylinders of CsCl, with approximately 2.5 cm of length, disposed linearly along a metallic guiding structure. The plastic bags containing the ricin samples were placed over a tray and introduced in one of the two irradiation chambers of the equipment. Samples were irradiated at dosages of 10 kGy, 20 kGy and 30 kGy.

The time of exposure to the irradiation source needed to achieve the desired dosage was calculated through software developed based on the dosimetric mapping of the irradiator. The calculations considered the current activity of the source and the density and geometry of the sample, among other factors. Equation (1) calculates the activity (A) of the source, in kCi·h^−1^, related to the year of the irradiation (t) \[[@B45-toxins-11-00201]\].

A = 108·e

−0.23(t − 1969)

Based on Equation (1) the value of A for the irradiator in the year of the experiment was of 2.75 Ci·h^−1^. The value found for the dosage absorbed by the samples was of 1.2 kGy·h^−1^. [Table 8](#toxins-11-00201-t008){ref-type="table"} lists the time of irradiation necessary for achieving the dosage desired for each sample.

4.6. MALDI-TOF MS Analysis {#sec4dot6-toxins-11-00201}
--------------------------

The samples were analyzed in a MALDI-TOF mass spectrometer, Bruker^®^, model microflex LRF. This equipment has a laser of N~2~, with a maximum frequency of 60 Hz, and minimal focus of 50 µm. Each sample was analyzed in triplicate. Firstly, 0.5 µL of solution of sinapinic acid (99% from Sigma-Aldrich (São Paulo, Brazil), saturated in ethanol (95% PA from ACS, Isofar (Duque de Caxias, Rio de Janeiro, Brazil), were applied in one of the spots of a stainless steel target plate. This solution was left to dry and a thin layer of matrix was formed. After, a second solution was prepared, this time containing sinapinic acid saturated in TA30 \[30% acetonitrile with 70% water/trifluoroacetic acid (99.9:0.1)\]. This solution was mixed in equal parts with a third solution, containing 2 mg/mL of the original sample diluted in 0.1% TFA/water. One aliquot of 0.5 µL of this mixture was collected and applied over the first matrix layer described above, left to dry and analyzed.

The analyses were performed in linear mode by monitoring the presence of peaks in the spectral region corresponding to masses between 50 and 70 kDa. All spectra were acquired by addition after 3000 laser shots, randomly distributed over the whole surface of the sample. The laser energy was kept constant in all shots.

4.7. Inequivocal Identification of Ricin in the Samples {#sec4dot7-toxins-11-00201}
-------------------------------------------------------

The identification of ricin in the samples was done through MALDI-TOF MS, using the PMF technique, after digestion of RTA and RTB.

### 4.7.1. SDS-PAGE Under Reducing Conditions {#sec4dot7dot1-toxins-11-00201}

SDS-PAGE of gels were made in an equipment Loccus, model LP3000. The racing and stacking gels were with 12% and 5% (*w*/*v*) of polyacrylamide, respectively. For each sample a 20 mg/mL PBS10 buffer solution (pH 7.4) was prepared. This solution (4 µL) was added to 8 µL of a charging buffer containing the colorant bromophenol blue and other reactants (the commercial product "Blue Loading Buffer Pack", from BioLabs was used, following instructions of the manufacturer with the addition of the reducing agent dithiothreitol). Finally, 10 µL of the charging solution was applied in one of the spots of a polyacrylamide gel. The bands were removed from the SDS-PAGE gel and identified through MALDI-TOF/MS.

The electrophoresis experiments were performed with a constant tension of 200 V until the migration line achieve 1 cm from the bottom. The gel was immersed in a solution containing ethanol/glacial acetic acid/water (45:10:45) and 1 g of the colorant Coomassie blue for 30 min under gentle stirring. The revelation was done overnight with a solution of methanol/glacial acetic acid/water (3:1:6) at room temperature. Solvents and reagents used were: bright Coomassie blue R250, 98.5%, from Vetec (Rio de Janeiro, Brazil); ethanol 95%, PA, from ACS, Isofar (Duque de Caxias, Rio de Janeiro, Brazil); glacial acetic acid 99.8%, PA, from ACS, Proquímios; methanol 100%, from ACS, J.T. Baker; and distilled and deionized water produced in the lab.

### 4.7.2. Proteolytic Digestion {#sec4dot7dot2-toxins-11-00201}

After revelation of the SDS-PAGE gel, each band related to the ricin chains was cut out with a stiletto and transferred to a 1 mL microcentrifuge tube, pre-washed twice with TA50 \[50% acetonitrile with 50% water/trifluoroacetic acid (99.9:0.1)\]. After, the samples were uncolored through two successive washes with 0.2 mL of a solution 100 mM of NH~4~HCO~3~/50% ACN, for 45 min at 37 °C. Then the samples were dehydrated by adding 100 µL of acetonitrile \[99.9%, UV/HPLC spectroscopic from Vetec (Rio de Janeiro, Brazil)\] for 10 min at room temperature, and dried under N~2~ flow at room temperature.

In parallel, aliquots were collected from the stock solution of trypsin (trypsin gold, mass spectrometry grade from Promega (Madison, Wisconsin, USA) 1 µg/µL in 50 mM of acetic acid, and diluted to 20 µg/mL with 40 mM NH~4~HCO~3~/10% ACN. The dried gel pieces were then incubated and rehydrated in 30 µL of this trypsin solution at room temperature for 1 h. After, the digestion buffer (40 mM NH~4~HCO~3~/10% ACN) was added until covering completely the gel pieces. The tubes were well closed to avoid evaporation and incubated overnight at 37 °C. The day after the solution was transferred to a clean tube and 30 µL of TA50 added to the gel, which was submitted to ultrasound for 20 minutes. The resulting solution was transferred to a clean tube and totally dried under N~2~ (AP, 99.997% from Linde) flow, being re-suspended again with 20 µL of the solution of TFA 0.1% in water. This sample, containing the peptides from the trypsin digestion was sent for analysis by MALDI-TOF MS.

[Table 9](#toxins-11-00201-t009){ref-type="table"} shows the peptides expected for the complete trypsinization of ricin, named according to its positions in the sequences of RTA and RTB.

### 4.7.3. MALDI-TOF MS Analysis for the Identification of Ricin {#sec4dot7dot3-toxins-11-00201}

The mixture of trypsin peptides extracted from each band of the SDS-PAGE gel was analyzed through MALDI-TOF MS using a saturated solution of 4-hydroxy-α-cyanocinnamic acid (HCCA) saturated in TA30 as a matrix. The sample preparation consisted of mixing equal volumes of the peptides solution in 0.1% TFA/water with a saturated solution of HCCA in TA30. After, 0.5 µL of this new mixture was applied over the target plate and left to dry. The analyses were performed in reflector mode, by monitoring the presence of peaks in the spectral region corresponding to the weight between 700 and 4000 Da. All spectra were obtained by addition of 2000 laser shots randomly distributed over the whole surface of the sample. The laser energy was kept constant during the shots.

The mass spectra of the mixture of peptides were used for the identification of ricin. Firstly, the *m*/*z* list of the peaks obtained was exported for the software Biotools, from Bruker. After, through the MASCOT PMF search mechanism, the experimental results were compared with the information available in the data banks of proteins SwissProt \[[@B36-toxins-11-00201]\] and NCBI \[[@B37-toxins-11-00201]\].

### 4.7.4. Analyses by MALDI-TOF MS/MS {#sec4dot7dot4-toxins-11-00201}

The results obtained by MALDI-TOF MS were confirmed by a second analytic spectrometric technique. For this, three peptides were chosen to have their amino acid sequences verified through MALDI-TOF MS/MS. The criteria established for the selection of the precursor ions were the intensity and the relevance of the peptide for the differentiation between ricin and other proteins, the absence of cysteine and methionine residues, and the possibility of the same peptide representing RTA and RTB.

The analyses were performed in the same target plate with the samples former prepared for the MALDI-TOF MS experiment. The equipment used also was the same used before. The spectra were obtained by the method known as fragmentation analysis and structural time of flight (FAST), which only works in the reflective mode. For each analysis the range of the ions selector and the number of segments were adjusted according to the mass of the precursor ion selected, avoiding interference of fragments from possible adjacent ions. The spectra were exported to the software Bruker Biotools and, with the help of the MASCOT searching mechanism, compared to the data existing in the data banks SwissProt \[[@B36-toxins-11-00201]\] and NCBI \[[@B37-toxins-11-00201]\].

4.8. Verification of the Toxic Activity of the Ricin Samples by MALDI-TOF MS {#sec4dot8-toxins-11-00201}
----------------------------------------------------------------------------

The toxic activity of ricin present in the samples was verified by MALDI-TOF MS, following a method adapted from Schieltz et al. \[[@B46-toxins-11-00201]\]. For this, a DNA substrate chemically synthesized with the nucleotide sequence GCGCGAGAGCGC, similar to rRNA 28S where the ricin attack occurs, was acquired from the Company Genone Biotechnologies (Rio de Janeiro, Brazil).

A solution containing 0.1 µmol/mL of nucleotides was prepared and mixed with a PBS10 buffer (pH 7.4). After, the sample solution was prepared with 20 mg/mL of the white powder extracted from castor bean seeds mixed with the PBS10 buffer solution. The reaction mixture was produced by mixing equal volumes of the two solutions. Then it was incubated at 37 °C, without stirring, for 24 h. Aliquots were collected and analyzed in times 0, 4 and 24 h. The matrix solution consisted of 3-hydroxypicolinic acid (3-HPA) saturated in TA50. This solution (0.5 µL) was applied over the target plate and left to dry at room temperature. At the time intervals mentioned above, 2.0 µL were collected from the supernatant of the reaction and mixed with more 18 µL of the matrix solution. From this mixture, one aliquot of 0.5 µL was deposited over the first layer, left for drying, and introduced in the target plate of the equipment.

The analysis method was in the reflective mode, with a range of *m*/*z* from 3000 to 4000, with the addition of spectra obtained after 2000 laser shots randomly distributed over the whole sample surface in the target plate.

We monitored the intensities of the signals of peaks at *m*/*z* 3,697, referring to the mass of the quasi-molecular ion of the oligonucleotide protonated \[M + H\]^+^ and in *m*/*z* 3564, related to the loss of adenine \[M+H-A\]^+^.

Solvents and reagents used for these experiments were: 3-hydroxypicolinic acid 99%, from Sigma Aldrich, TA50 (produced with acetonitrile 99,9%, UV/HPLC spectroscopic, from Vetec (Rio de Janeiro, Brazil); trifluoroacetic acid 99% from Sigma Aldrich and distilled and deionized water); PBS10 (prepared with Na~2~HPO~4~ 99% from Sigma Aldrich; NaH~2~PO~4~·H~2~O 98% from Sigma Aldrich and NaCl, ACS reagent, from Vetec (Rio de Janeiro, Brazil).
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![SDS-PAGE gel of samples irradiated at 0, 10, 20 and 30 kGy. M = marker. The bands of interest were identified with numbers 1 and 2. They were removed from the gel and identified by MALDI-TOF/MS..](toxins-11-00201-g002){#toxins-11-00201-f002}
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![MALDI-TOF MS mass spectra obtained for band 2 of the SDS-PAGE gel of the ricin samples. (**A**) Non-irradiated and (**B**) irradiated with 30 kGy. Magnification of the mass spectra in the region of peptides B1 and B6 is shown in the spectra of the non-irradiated sample.](toxins-11-00201-g004){#toxins-11-00201-f004}

![MALDI-TOF MS/MS spectra corresponding to the fragments of precursor ion *m*/*z* 1310 (**A**). Analysis of the MALDI-TOF MS/MS spectra of the precursor ion *m*/*z* 1310 (**B**).](toxins-11-00201-g005){#toxins-11-00201-f005}

![MALDI-TOF MS/MS spectra corresponding to the precursor ion *m*/*z* 3307 (**A**). Analysis of the MALDI-TOF MS/MS spectrum of the precursor ion *m*/*z* 3307 (**B**).](toxins-11-00201-g006){#toxins-11-00201-f006}

![MALDI-TOF MS/MS spectrum corresponding to the fragments of the precursor ion *m*/*z* 2231. (**A**) Analysis of the MALDI-TOF MS/MS spectrum of the precursor ion *m*/*z* 2231 (**B**).](toxins-11-00201-g007){#toxins-11-00201-f007}

![Verification of the toxic activity of ricin by MALDI-TOF MS. (**a**) Control at 0 h; (**b**) Sample 0 kGy at 0 h (**c**) Sample 30 kGy at 0 h; (**d**) Control after 4 h; (**e**) Sample 0 kGy after 4 h (**f**) Sample 30 kGy after 4 h; (**g**) Control after 24 h; (**h**) Sample 0 kGy after 24 h (**i**) Sample 30 kGy after 24 h.](toxins-11-00201-g008){#toxins-11-00201-f008}

![Scheme of preparation and analysis of the ricin samples.](toxins-11-00201-g009){#toxins-11-00201-f009}

toxins-11-00201-t001_Table 1

###### 

Ratio signal to noise (S/N) of ricin in the samples for each irradiation dosage (average values, three repetitions).

  --------------------------------------------------------------------------------------------------
  Irradiation Dosage (kGy)   Intensity Signal/Noise (S/N)   (S/N of Sample)/\
                                                            (S/N of the Non-Irradiated Sample) (%)
  -------------------------- ------------------------------ ----------------------------------------
  0                          18.1                           100.00

  10                         6.2                            34.12

  20                         1.5                            8.19

  30                         0.5                            2.53
  --------------------------------------------------------------------------------------------------

toxins-11-00201-t002_Table 2

###### 

Ricin peptides identified by MALDI-TOF MS in the band 1 of the non-irradiated sample.

  Peptides          Positions   Amino Acids Sequence                    \[M + H\]^+^ Theoretical   *m*/*z* Measured
  ----------------- ----------- --------------------------------------- -------------------------- ------------------
  A1 + A2           1--26       IFPKQYPIINFTTAGATVQSYTNFIR              2990.577                   2990.6
  A6                40--48      HEIPVLPNR                               1074.605                   1074.3
  A7 + A8           49--85      VGLPINQRFILVELSNHAELSVTLALDVTNAYVVGYR   4084.222                   2042.4 ^a^
  A9                86--114     AGNSAYFFHPDNQEDAEAITHLFTDVQNR           3307.504                   3306.8
  1654.4 ^a^                                                                                       
  A10               115--125    YTFAFGGNYDR                             1310.580                   1310.3
  A11               126--134    LEQLAGNLR                               1013.574                   1013.3
  A10 + A11         115--134    YTFAFGGNYDRLEQLAGNLR                    2305.136                   2304.6
  A12               135--166    ENIELGNGPLEEAISALYYYSTGGTQLPTLAR        3440.722                   3440.9
  A13               167--180    SFIICIQMISEAAR                          1652.849 ^b^               1653.9
  A13 + A14         167--189    SFIICIQMISEAARFQYIEGEMR                 2806.370 ^b^               2806.6
  A14               181--189    FQYIEGEMR                               1172.540                   1172.3
  A14               181--189    FQYIEGEMR                               1188.535 ^c^               1188.2
  A16 + A17         192--196    IRYNR                                   721.410                    721.9
  A16 + A17 + A18   192--197    IRYNRR                                  877.512                    876.8
  A19               198--213    SAPDPSVITLENSWGR                        1728.855                   1728.4
  A20               214--234    LSTAIQESNQGAFASPIQLQR                   2259.173                   2258.7
  A23               240--258    FSVYDVSILIPIIALMVYR                     2228.240 ^c^               2228.5

^a^ Value corresponding to the double protonated ion. ^b^ Considering the formation of the polyacrylamide adduct; ^c^ Considering oxidation of methionine to methionine sulfoxide.

toxins-11-00201-t003_Table 3

###### 

Comparison between the amino acid sequences of RTA and RCA120 between positions 85 and 126 \*.

  Protein   Amino Acid Sequences between Positions 85 and 126 of Chain A for Ricin and RCA120
  --------- -----------------------------------------------------------------------------------
  Ricin     **\...R^85^AGNSAYFFHPDNQEDAEAITHLFTDVQN[RY]{.ul}TFAFGGNYDRL^126^\...**
  RCA120    **\...R^85^AGNSAYFFHPDNQEDAEAITHLFTDVQN[SF]{.ul}TFAFGGNYDRL^126^\...**

\* Different amino acids in both sequences are underlined. The digestion with trypsin leads to peptides A9 (in red) and A10 (in blue) in ricin but keeps RCA120 as a single peptide (in green).

toxins-11-00201-t004_Table 4

###### 

Peptides identified by MALDI-TOF MS in band 2 of the non-irradiated sample.

  Peptides          Positions   Amino Acids Sequence                    \[M + H\]^+^ Theoretical   *m*/*z* Measured
  ----------------- ----------- --------------------------------------- -------------------------- ------------------
  A1 + A2           1--26       IFPKQYPIINFTTAGATVQSYTNFIR              2990.577                   2991.5
  A16 + A17 + A18   192--197    IRYNRR                                  877.512                    877.2
  A6                40--48      HEIPVLPNR                               1074.605                   1074.7
  A7 + A8           49--85      VGLPINQRFILVELSNHAELSVTLALDVTNAYVVGYR   4084.222                   2043.0
  A9                86--114     AGNSAYFFHPDNQEDAEAITHLFTDVQNR           3307.504                   3307.7
  A10               115--125    YTFAFGGNYDR                             1310.580                   1310.7
  A11               126--134    LEQLAGNLR                               1013.574                   1013.6
  A14               181--189    FQYIEGEMR                               1172.540                   1172.6
  A19               198--213    SAPDPSVITLENSWGR                        1728.855                   1728.9
  A20               214--234    LSTAIQESNQGAFASPIQLQR                   2259.173                   2259.3
  A23               240--258    FSVYDVSILIPIIALMVYR                     2228.240 ^a^               2229.1
  B1                1--12       ADVCMDPEPIVR                            1415.666                   1415.8
  B6                41--52      SNTDANQLWTLK                            1390.696                   1390.8
  B6 + B7           41--53      SNTDANQLWTLKR                           1546.797                   1546.8
  B13               169--182    AEQQWALYADGSIRPQQNR                     2231.095                   2230.9
  B15 + B16 + B17               ETVVKILSCGPASSGQRWMF K                  2395.226                   2396.1
  B17 + B18 + B19   216--243    WMFKNDGTILNLYSGLVLDVRASDPSLK            3152.645                   3153.1
  B6 \*             RCA120      SNTDWNQLWTLR                            1533.744                   1533.8
  B18 \*                        NDGTILNLYNGLVLDVR                       1889.013                   1889.1

^a^ Considering the oxidation of methionine to methionine sulfoxide. \* Peptide of RCA120.

toxins-11-00201-t005_Table 5

###### 

Fragments of peptide A10 identified by MALDI-TOF MS/MS.

  Ions        Amino Acid Sequences   *m*/*z* Theoretical   *m*/*z* Measured
  ----------- ---------------------- --------------------- ------------------
  precursor   YTFAFGGNYDR            1310.580              1310.4
  b2          YT                     265.118               265.0
  b3          YTF                    412.187               412.0
  b4          YTFA                   483.224               483.2
  y1          R                      175.119               175.0
  y2          DR                     290.146               290.0
  y3          YDR                    453.209               453.0
  y4          NYDR                   567.252               567.1
  y5          GNYDR                  624.274               623.9
  y6          GGNYDR                 681.295               680.8
  y7          FGGNYDR                828.363               828.1
  y8          AFGGNYDR               899.401               899.2
  y9          FAFGGNYDR              1046.469              1046.2

toxins-11-00201-t006_Table 6

###### 

Fragments of peptide A9 (AGNSAYFFHPDNQEDAEAITHLFTDVQNR) identified by MALDI-TOF MS/MS.

  Ions        Corresponding Amino Acids Sequence   *m*/*z* Theoretical   *m*/*z* Measured
  ----------- ------------------------------------ --------------------- ------------------
  precursor   AGNSAYFFHPDNQEDAEAITHLFTDVQNR        3307.504              3307.4
  b3          AGN                                  243.109               243.1
  b4          AGNS                                 330.141               329.7
  b7          AGNSAYF                              711.310               711.3
  b9          AGNSAYFFH                            995.437               995.2
  b12         AGNSAYFFHPDN                         1321.560              1321.7
  b15         AGNSAYFFHPDNQED                      1693.688              1693.8
  b23         AGNSAYFFHPDNQEDAEAITHLF              2576.148              2576.6
  b25         AGNSAYFFHPDNQEDAEAITHLFTD            2792.222              2792.1
  y1          R                                    175.119               175.5
  y3          QNR                                  417.220               417.1
  y4          VQNR                                 516.289               515.8
  y5          DVQNR                                631.316               631.0
  y6          TDVQNR                               732.363               732.0
  y7          FTDVQNR                              879.432               879.1
  y8          LFTDVQNR                             992.516               992.7
  y9          HLFTDVQNR                            1129.575              1129.4
  y11         ITHLFTDVQNR                          1343.707              1343.5
  y12         AITHLFTDVQNR                         1414,744              1415.0
  y13         EAITHLFTDVQNR                        1543.786              1544.1
  y14         AEAITHLFTDVQNR                       1614.823              1614.8
  y15         DAEAITHLFTDVQNR                      1729.850              1730.0
  y16         EDAEAITHLFTDVQNR                     1858.893              1858.7
  y17         QEDAEAITHLFTDVQNR                    1986.952              1987.0
  y18         NQEDAEAITHLFTDVQNR                   2100.994              2100.4
  y20         PDNQEDAEAITHLFTDVQNR                 2313.074              2313.5
  y21         HPDNQEDAEAITHLFTDVQNR                2450.133              2450.3
  y22         FHPDNQEDAEAITHLFTDVQNR               2597.202              2597.5
  y25         AYFFHPDNQEDAEAITHLFTDVQNR            2978.370              2978.2
  y26         SAYFFHPDNQEDAEAITHLFTDVQNR           3065.402              3065.6

toxins-11-00201-t007_Table 7

###### 

Fragments of peptide B13 (AEQQWALYADGSIRPQQNR) identified by MALDI-TOF MS/MS.

  Ions        Corresponding Amino Acids Sequence   *m*/*z* Theoretical   *m*/*z* Measured
  ----------- ------------------------------------ --------------------- ------------------
  precursor   AEQQWALYADGSIRPQQNR                  2231.095              2231.0
  b3          AEQ                                  329.146               328.8
  b4          AEQQ                                 457.204               457.0
  b6          AEQQWA                               714.321               714.4
  b14         AEQQWALYADGSIR                       1589.771              1589.7
  b18         AEQQWALYADGSIRPQQN                   2056.984              2057.3
  y1          R                                    175.119               175.0
  y5          PQQNR                                642.332               642.3
  y9          GSIRPQQNR                            1055.570              1055.3
  y14         ALYADGSIRPQQNR                       1588.819              1588.9

toxins-11-00201-t008_Table 8

###### 

Time needed for each sample.

  Irradiation Dosage Absorbed   Exposure Time
  ----------------------------- ---------------
  10 kGy                        8 h 20 min
  20 kGy                        16 h 40 min
  30 kGy                        25 h 00 min

toxins-11-00201-t009_Table 9

###### 

Expected peptides from the total proteolysis of ricin with trypsin.

  Abbreviation   Position   Sequence of Amino Acids                                              Molecular Mass (M)
  -------------- ---------- -------------------------------------------------------------------- --------------------
  A1             36--39     IFPK                                                                 504.3
  A2             40--61     QYPIINFTTAGATVQSYTNFIR                                               2504.3
  A3             62--64     AVR                                                                  344.2
  A4             65--66     GR                                                                   231.1
  A5             67--74     LTTGADVR                                                             831.4
  A6             75--83     HEIPVLPNR                                                            1073.6
  A7             84--91     VGLPINQR                                                             895.5
  A8             92--120    FILVELSNHAELSVTLALDVTNAYVVGYR                                        3205.7
  A9             121--149   AGNSAYFFHPDNQEDAEAITHLFTDVQNR                                        3306.5
  A10            150--160   YTFAFGGNYDR                                                          1309.6
  A11            161--169   LEQLAGNLR                                                            1012.6
  A12            170--201   ENIELGNGPLEEAISALYYYSTGGTQLPTLAR                                     3439.7
  A13            202--215   SFIICIQMISEAAR                                                       1580.8
  A14            216--224   FQYIEGEMR                                                            1171.5
  A15            225--226   TR                                                                   275.2
  A16            227--228   IR                                                                   287.2
  A17            229--231   YNR                                                                  451.2
  A18            232--232   R                                                                    174.1
  A19            233--248   SAPDPSVITLENSWGR                                                     1727.9
  A20            249--269   LSTAIQESNQGAFASPIQLQR                                                2258.2
  A21            270--270   R                                                                    174.1
  A22            271--274   NGSK                                                                 404.2
  A23            275--293   FSVYDVSILIPIIALMVYR                                                  2211.2
  A24            294--302   CAPPPSSQF                                                            932.4
  B1             315--326   ADVCMDPEPIVR                                                         1343.6
  B2             327--330   IVGR                                                                 443.3
  B3             331--338   NGLCVDVR                                                             874.4
  B4             339--341   DGR                                                                  346.2
  B5             342--354   FHNGNAIQLWPCK                                                        1526.8
  B6             355--366   SNTDANQLWTLK                                                         1389.7
  B7             367--367   R                                                                    174.1
  B8             368--372   DNTIR                                                                617.3
  B9             373--376   SNGK                                                                 404.2
  B10            373--376   CLTTYGYSPGVYVMIYDCNTAATDATR                                          2948.3
  B11            404--416   WQIWDNGTIINPR                                                        1611.8
  B12            417--482   SSLVLAATSGNSGTTLTVQTNIYAVSQGWLPTNNTQPFVTTIVGLYGLCLQANSGQVWIEDCSSEK   6932.4
  B13            417--482   AEQQWALYADGSIRPQQNR                                                  2230.1
  B14            502--512   DNCLTSDSNIR                                                          1236.5
  B15            513--517   ETVVK                                                                574.3
  B16            518--529   ILSCGPASSGQR                                                         1174.6
  B17            530--533   WMFK                                                                 610.3
  B18            534--550   NDGTILNLYSGLVLDVR                                                    1861.0
  B19            551--557   ASDPSLK                                                              716.4
  B20            558--576   QIILYPLHGDPNQIWLPLF                                                  2276.2
